Atlas Trials

A Prospective Study to Examine the Need to Adjust the Dose of Apixaban When Used in Atrial Fibrillation and Obesity

Clinical trial NCT03893591 · COMPLETED

Trial details

NCT number
NCT03893591
Sponsor
HaEmek Medical Center, Israel
Status
COMPLETED
Study type
OBSERVATIONAL
AnticoagulantApixabanObesity
Start date
2019-05-06
Primary completion
2020-02-29
Enrollment
82

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.